LIC MF Healthcare Fund Regular G
Summary Info
Fund Name
: LIC Mutual Fund
Scheme Name
: LIC MF Healthcare Fund Regular G
AMC
: LIC Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 08-Feb-2019
Fund Manager
: Karan Doshi
Net Assets (Rs. cr)
: 82.69
LIC MF Healthcare Fund Regular G - Nav Details
Nav Date
: 30-Apr-2025
NAV [Rs.]
: 28.0267
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.
LIC MF Healthcare Fund Regular G- NAV Chart
LIC MF Healthcare Fund Regular G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.27 | -0.88 | -1.43 | -5.35 | 16.31 | 15.95 | 17.3 | 18.17 |
| Category Avg | -1.12 | 1.68 | 0.51 | -3.09 | 18.2 | 20.8 | 22.96 | 17.39 |
| Category Best | -0.41 | 3.78 | 3.94 | 1.11 | 29.29 | 25.36 | 26.44 | 36.61 |
| Category Worst | -2.32 | -0.88 | -4.74 | -9.69 | 5.59 | 15.99 | 17.31 | -7.76 |
LIC MF Healthcare Fund Regular G- Latest Dividends
No Records Found
LIC MF Healthcare Fund Regular G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 500
In & Out
In
InName Of The CompanyNo Of Shares
Sanofi Consumer1,749
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.03 | 47814 | 8.29 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 5.90 | 216988 | 4.87 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.29 | 13548 | 4.37 |
| Equity | Artemis Medicare | Healthcare Services | 5.09 | 153796 | 4.20 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 4.59 | 24614 | 3.79 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 4.26 | 24402 | 3.51 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 3.93 | 5620 | 3.24 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.78 | 6409 | 3.12 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.71 | 998 | 3.06 |
| Equity | Syngene Intl. | Healthcare Services | 3.57 | 40626 | 2.95 |
| Equity | Apollo Hospitals | Healthcare Services | 3.52 | 4399 | 2.91 |
| Equity | Global Health | Healthcare Services | 3.51 | 24197 | 2.89 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.49 | 6847 | 2.88 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 3.43 | 18894 | 2.83 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 3.36 | 62230 | 2.77 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 3.29 | 2253 | 2.71 |
| Equity | OneSource Speci. | Pharmaceuticals & Biotechnology | 3.13 | 14751 | 2.58 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.12 | 10634 | 2.57 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 3.03 | 21579 | 2.50 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.99 | 15222 | 2.47 |
| Equity | Vinati Organics | Chemicals & Petrochemicals | 2.84 | 14857 | 2.34 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.79 | 26041 | 2.30 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 2.27 | 11162 | 1.87 |
| Equity | Metropolis Healt | Healthcare Services | 2.23 | 11780 | 1.84 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 1.96 | 26393 | 1.61 |
| Equity | Suven Pharma | Pharmaceuticals & Biotechnology | 1.94 | 13935 | 1.60 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.02 | 1749 | 0.84 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 2.94 | 0 | 2.43 |
| Net CA & Others | Net CA & Others | -/- | -0.97 | 0 | -0.80 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
36,564.37
Trustee/s:
LIC Mutual Fund Trustee P, Mr. Pradeep Jagannath Bhi, Mr. Rammohan Nilkanth Bha
Chairman:
NA
CEO / MD:
Ravi Kumar Jha, T.S. Ramakrishnan
CIO:
NA
President:
NA
Director/s:
Sanjay Achyutrao Muthal, Praveen Garg, Raghunandan Maluste, Vijay Sharma, Siddhartha Mohanty
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP
OTHER INFORMATION
Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Email:
Website:
